2.5 ML sodium hyaluronate 10 MG/ML Prefilled Syringe [Trivisc]
RxNorm concept 2109948, branded drug (sbd). Prescribable name: TriVisc 25 MG in 2.5 mL Prefilled Syringe.
- RxCUI
- 2109948
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2109948 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
2.5 ML Trivisc 10 MG/ML Prefilled Syringe; Trivisc 25 MG per 2.5 ML Prefilled Syringe
Related concepts
- sodium hyaluronate 10 MG/ML (SCDC, consists of)
- sodium hyaluronate 10 MG/ML [Trivisc] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Trivisc (BN, has ingredient)
- 2.5 ML sodium hyaluronate 10 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
- 50653000604
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2109948 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2109948 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2109948. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.